[Cerebral and myocardial perfusion in patients with arterial hypertension and metabolic syndrome after monotherapy with combined drug noliprel].
Sergienko
V B
VB
Gornostaev
V V
VV
Bugriĭ
M E
ME
Mychka
V B
VB
Chazova
I E
IE
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology*; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology*; D004232:Diuretics / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D007190:Indapamide / Q000627:therapeutic use*; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D020913:Perindopril / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D004338:Drug Combinations; D007190:Indapamide; D020913:Perindopril